Company / Revenue
ABEONA THERAPEUTICS INC. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$5.8M
FY2025
5-year range
$1.4M / $10.0M
FY2021-FY2025
Trend
+66.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $837,000 in FY2019 to $10M in FY2021.
Based on SEC 10-K filings.
$6M in FY2025 with a 5-year CAGR of -10.3%.
Improved from $1M to $6M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +24.7%
- 5-Year CAGR
- -10.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -10.3%, indicating a declining trend.
- In FY2025, revenue increased 66.3% year-over-year.
- Peak revenue was recorded in FY2021.
- Lowest revenue in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.8M | +66.3% |
| FY2024 | $3.5M | +147.5% |
| FY2023 | $1.4M | -52.9% |
| FY2022 | $3.0M | -70.0% |
| FY2021 | $10.0M | +0.0% |
| FY2020 | $10.0M | +1094.7% |
| FY2019 | $837.0K | -72.1% |
| FY2018 | $3.0M | +258.2% |
| FY2017 | $837.0K | -19.5% |
| FY2016 | $1.0M | +12.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026